Silvant Capital Management’s Encompass Health EHC Stock Holding History

Silvant Capital Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,689	Closed	-$2.3M	–	319
2025 Q4	$2.3M	Buy	21,689 +348	+2%	+$40.3K	0.08%	125
2025 Q3	$2.71M	Buy	21,341 +1,668	+8%	+$199K	0.09%	116
2025 Q2	$2.41M	Buy	+19,673	New	+$2.25M	0.09%	118
2021 Q3	–	Sell	-4,519	Closed	-$282K	–	332
2021 Q2	$282K	Hold	4,519	–	–	0.04%	161
2021 Q1	$295K	Sell	4,519 -3,115	-41%	-$203K	0.05%	158
2020 Q4	$504K	Hold	7,634	–	–	0.09%	122
2020 Q3	$396K	Sell	7,634 -2,667	-26%	-$137K	0.07%	124
2020 Q2	$510K	Hold	10,301	–	–	0.09%	111
2020 Q1	$527K	Hold	10,301	–	–	0.11%	100
2019 Q4	$570K	Hold	10,301	–	–	0.1%	104
2019 Q3	$521K	Hold	10,301	–	–	0.1%	104
2019 Q2	$521K	Hold	10,301	–	–	0.09%	109
2019 Q1	$481K	Hold	10,301	–	–	0.09%	117
2018 Q4	$508K	Hold	10,301	–	–	0.1%	109
2018 Q3	$641K	Hold	10,301	–	–	0.08%	110
2018 Q2	$557K	Hold	10,301	–	–	0.07%	111
2018 Q1	$471K	Buy	+10,301	New	+$442K	0.06%	121

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Silvant Capital Management's EHC Position: Q1 2026 in Review

Silvant Capital Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 21,689 shares — an estimated $2.3M sold.

Silvant Capital Management first reported a position in EHC in Q1 2018 and held it in 17 quarters. The position peaked at $2.71M in Q3 2025. 580 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Silvant Capital Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
Silvant Capital Management sold 21,689 Encompass Health shares in Q1 2026, an estimated $2.3M.
Silvant Capital Management first reported a position in Encompass Health in Q1 2018 and held it in 17 quarters.
Silvant Capital Management's Encompass Health position peaked at $2.71M in Q3 2025.
580 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.